ArticleAnnals of surgical oncology2014

Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).

Pat Whitworth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.